Literature DB >> 16146733

Controlled gene activation and inactivation in the mouse.

Moisés Mallo1.   

Abstract

The emergence of techniques that allow fine manipulation of gene expression in the mouse have changed the way biomedically relevant processes are studied, as they allow their analysis in the living animal. In addition, this has opened the possibility to generate animal models for several human diseases, which are useful both for understanding the disease' s physiopathological mechanisms and for the eventual evaluation of novel therapeutic approaches. Many of the gene manipulation systems currently employed in the mouse are based on regulatory mechanisms normally operating in yeast and prokaryotic organisms. This has allowed specific experimental control with very limited unspecific interference with the normal physiology of the cell. Some of these systems use elements that permit transcriptional regulation of a particular gene or genes. Among them, I will discuss in detail the tet, lac and Gal4/UAS systems, which are among the most popular of these transcriptional systems because they can be used to achieve spatial and temporal control on the expression of a specific gene in a reversible fashion. The other major group of systems currently employed to manipulate gene expression in the mouse is based on site-specific recombination reactions. The Cre/lox and FLP/FRT systems are the most popular of these. I will discuss how these recombination systems are used in the mouse with special focus on their use to achieve specific gene activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16146733     DOI: 10.2741/1799

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  17 in total

1.  Refined spatial manipulation of neuronal function by combinatorial restriction of transgene expression.

Authors:  Haojiang Luan; Nathan C Peabody; Charles R Vinson; Benjamin H White
Journal:  Neuron       Date:  2006-11-09       Impact factor: 17.173

Review 2.  The energy hypothesis of sleep revisited.

Authors:  Matthew T Scharf; Nirinjini Naidoo; John E Zimmerman; Allan I Pack
Journal:  Prog Neurobiol       Date:  2008-09-03       Impact factor: 11.685

3.  Near-infrared optogenetic pair for protein regulation and spectral multiplexing.

Authors:  Taras A Redchuk; Evgeniya S Omelina; Konstantin G Chernov; Vladislav V Verkhusha
Journal:  Nat Chem Biol       Date:  2017-03-27       Impact factor: 15.040

4.  Myocyte TLR4 enhances enteric and systemic inflammation driving late murine endotoxic ileus.

Authors:  Bettina M Buchholz; Richard A Shapiro; Yoram Vodovotz; Timothy R Billiar; Chhinder P Sodhi; David J Hackam; Anthony J Bauer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-06       Impact factor: 4.052

5.  A Sox10(rtTA/+) Mouse Line Allows for Inducible Gene Expression in the Auditory and Balance Organs of the Inner Ear.

Authors:  Bradley J Walters; Jian Zuo
Journal:  J Assoc Res Otolaryngol       Date:  2015-04-21

6.  Targeted gene expression in the transgenic Aedes aegypti using the binary Gal4-UAS system.

Authors:  Vladimir A Kokoza; Alexander S Raikhel
Journal:  Insect Biochem Mol Biol       Date:  2011-04-27       Impact factor: 4.714

7.  Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis.

Authors:  Ken Kataoka; Dae Joon Kim; Steve Carbajal; John L Clifford; John DiGiovanni
Journal:  Carcinogenesis       Date:  2008-05-02       Impact factor: 4.944

Review 8.  Pharmacosynthetics: Reimagining the pharmacogenetic approach.

Authors:  Martilias S Farrell; Bryan L Roth
Journal:  Brain Res       Date:  2012-10-09       Impact factor: 3.252

9.  The intersectional genetics landscape for humans.

Authors:  Andre Macedo; Alisson M Gontijo
Journal:  Gigascience       Date:  2020-08-01       Impact factor: 6.524

10.  Disruption of Foxg1 expression by knock-in of cre recombinase: effects on the development of the mouse telencephalon.

Authors:  K L Eagleson; L J Schlueter McFadyen-Ketchum; E T Ahrens; P H Mills; M D Does; J Nickols; P Levitt
Journal:  Neuroscience       Date:  2007-07-19       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.